{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:48Z","timestamp":1761919308394},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10067-010-1414-6","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T20:55:26Z","timestamp":1268427326000},"page":"683-686","source":"Crossref","is-referenced-by-count":24,"title":["Proposing an algorithm for treatment of different manifestations of neuro-Behcet\u2019s disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Afshin","family":"Borhani Haghighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahid","family":"Safari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,13]]},"reference":[{"key":"1414_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.nrl.0000156343.16797.c4","volume":"11","author":"A Borhani Haghighi","year":"2005","unstructured":"Borhani Haghighi A, Pourmand R, Nikseresht AR (2005) Neuro-Behcet\u2019s disease: a review. The Neurologist 11:80\u201389","journal-title":"The Neurologist"},{"issue":"10","key":"1414_CR2","first-page":"1542","volume":"27","author":"A Borhani Haghighi","year":"2006","unstructured":"Borhani Haghighi A, Samangooei S, Ashjazadeh N et al (2006) Neurological manifestation of Behcet\u2019s disease. Saudi Med J 27(10):1542\u20131546","journal-title":"Saudi Med J"},{"key":"1414_CR3","first-page":"362","volume":"245","author":"A Siva","year":"1998","unstructured":"Siva A, Kantarcy O, Saip S, Hamuryudan V, Altyntas A, Yazici H (1998) Neuro-Behcet syndrome: prognostic factors and survival. J Neurol 245:362","journal-title":"J Neurol"},{"key":"1414_CR4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D et al (2008) EULAR recommendations for the management of Behcet\u2019s disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 67:1656\u20131662","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1414_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/ern.09.11","volume":"9","author":"A Borhani Haghighi","year":"2009","unstructured":"Borhani Haghighi A (2009) Treatment of Neuro-Behcet\u2019s disease: an update. Exp Rev Neurother 9(4):565\u2013574","journal-title":"Exp Rev Neurother"},{"issue":"5","key":"1414_CR6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Behcet\u2019s syndrome. N Engl J Med 322(5):326\u2013328","journal-title":"N Engl J Med"},{"issue":"4","key":"1414_CR7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N et al (1997) Azathioprine in Behcet\u2019s syndrome: effects on long-term prognosis. Arthritis Rheum 40(4):769\u2013774","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1414_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","volume":"159","author":"S Hirohata","year":"1998","unstructured":"Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet\u2019s disease. J Neurol Sci 159(2):181\u2013185","journal-title":"J Neurol Sci"},{"key":"1414_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","volume":"528","author":"H Kikuchi","year":"2003","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2003) Low dose MTX for progressive neuro-Behcet\u2019s disease. A follow-up study for 4\u00a0years. Adv Exp Med Biol 528:575\u2013578","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"1414_CR10","first-page":"438","volume":"143","author":"M Hamza","year":"1992","unstructured":"Hamza M, Meddeb S, Mili I, Ouertani A (1992) Bolus of cyclophosphamide and methylprednisolone in uveitis in Behcet\u2019s disease. Preliminary results with the use of new criteria of evaluation. Ann Med Interne (Paris) 143(7):438\u2013441","journal-title":"Ann Med Interne (Paris)"},{"issue":"9","key":"1414_CR11","first-page":"1355","volume":"19","author":"LT Du","year":"1990","unstructured":"Du LT, Fain O, Wechsler B, Cochereau I et al (1990) Value of \u201cbolus\u201d cyclophosphamide injections in Behcet\u2019s disease. Experience of 17 cases. Presse Med 19(9):1355\u20131358","journal-title":"Presse Med"},{"issue":"5","key":"1414_CR12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Behcet\u2019s disease\u2014review and basis for recommendations. Rheumatology (Oxford) 46(5):736\u2013741","journal-title":"Rheumatology (Oxford)"},{"key":"1414_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","volume":"76","author":"JD O\u2019Duffy","year":"1984","unstructured":"O\u2019Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephaliltis of Behcet\u2019s disease. Am J Med 76:75\u201384","journal-title":"Am J Med"},{"key":"1414_CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","volume":"33","author":"I Kotter","year":"2004","unstructured":"Kotter I, Gunaydin I, Zierhut M, Stubiger N (2004) The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 33:320\u2013335","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1414_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","volume":"27","author":"JK Ahn","year":"2008","unstructured":"Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS (2008) Treatment of venous thrombosis associated with Behcet\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27(2):201\u2013205","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1414_CR16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S (2007) Behcet\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3(3):148\u2013155","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1414_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004150170154","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451\u2013468","journal-title":"J Neurol"},{"key":"1414_CR18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.1780270713","volume":"27","author":"I Bank","year":"1984","unstructured":"Bank I, Weart C (1984) Dural sinus thrombosis in Behcet\u2019s disease. Arthritis Rheum 27:816\u2013818","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1414_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/00015458.1999.12098496","volume":"99","author":"S Barlas","year":"1999","unstructured":"Barlas S (1999) Behcet\u2019s disease. An insight from a vascular surgeon\u2019s point of view. Acta Chir Belg 99(6):274\u2013281","journal-title":"Acta Chir Belg"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1414-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T19:48:47Z","timestamp":1635104927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1414-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,13]]}}}